Microbot Medical Stock Performance
| MBOT Stock | USD 0.99 0.01 1.02% |
Microbot Medical has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Microbot Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Microbot Medical is expected to be smaller as well. Microbot Medical right now secures a risk of 3.05%. Please verify Microbot Medical jensen alpha and the relationship between the value at risk and day median price , to decide if Microbot Medical will be following its current price movements.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Microbot Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Last Split Factor 1:15 | Dividend Date 2018-09-05 | Last Split Date 2018-09-05 |
1 | Microbot Medical Announces the Successful Enrollment of 50 percent of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surg... | 09/17/2024 |
2 | Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of L... | 10/15/2024 |
| Begin Period Cash Flow | 2.5 M |
Microbot |
Microbot Medical Relative Risk vs. Return Landscape
If you would invest 95.00 in Microbot Medical on August 28, 2024 and sell it today you would earn a total of 4.00 from holding Microbot Medical or generate 4.21% return on investment over 90 days. Microbot Medical is currently generating 0.1104% in daily expected returns and assumes 3.0477% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Microbot, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Microbot Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbot Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Microbot Medical, and traders can use it to determine the average amount a Microbot Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0362
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | MBOT | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.05 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Microbot Medical is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Microbot Medical by adding it to a well-diversified portfolio.
Microbot Medical Fundamentals Growth
Microbot Stock prices reflect investors' perceptions of the future prospects and financial health of Microbot Medical, and Microbot Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microbot Stock performance.
| Return On Equity | -1.34 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 12.35 M | ||||
| Shares Outstanding | 16.93 M | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 4.36 X | ||||
| EBITDA | (10.63 M) | ||||
| Net Income | (10.74 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 231 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | (8.53 M) | ||||
| Earnings Per Share | (0.79) X | ||||
| Market Capitalization | 16.59 M | ||||
| Total Asset | 8.33 M | ||||
| Retained Earnings | (79.5 M) | ||||
| Working Capital | 4.13 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
About Microbot Medical Performance
Assessing Microbot Medical's fundamental ratios provides investors with valuable insights into Microbot Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Microbot Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (423.87) | (402.67) | |
| Return On Tangible Assets | (1.29) | (1.23) | |
| Return On Capital Employed | (2.17) | (2.06) | |
| Return On Assets | (1.29) | (1.23) | |
| Return On Equity | (2.39) | (2.27) |
Things to note about Microbot Medical performance evaluation
Checking the ongoing alerts about Microbot Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microbot Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microbot Medical has some characteristics of a very speculative penny stock | |
| Microbot Medical had very high historical volatility over the last 90 days | |
| Net Loss for the year was (10.74 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Microbot Medical currently holds about 9.29 M in cash with (8.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Microbot Medical has a frail financial position based on the latest SEC disclosures |
- Analyzing Microbot Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microbot Medical's stock is overvalued or undervalued compared to its peers.
- Examining Microbot Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microbot Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microbot Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Microbot Medical's stock. These opinions can provide insight into Microbot Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.